Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006
Medication labelWhy this: Advisory · dailymed-prescription
Efavirenz, emtricitabine and tenofovir disoproxil fumarate tabletsare indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg.
- generic_name
- efavirenz, emtricitabine and tenofovir disoproxil fumarate
- product_names
- Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate
- ndc
- 72162-2565, 65862-497, 72162-2565-3
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en